Drug Profile
Acecainide
Alternative Names: ASL 601; N-AcetylprocainamideLatest Information Update: 13 Jul 1999
Price :
$50
*
At a glance
- Originator King Pharmaceuticals Research and Development; Pfizer
- Class Benzamides; Class III antiarrhythmics
- Mechanism of Action Potassium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Arrhythmias
Most Recent Events
- 13 Jul 1999 Discontinued-III for Arrhythmias in USA (IV)
- 01 Jul 1998 Phase-III clinical trials for Arrhythmias in USA (IV)